USPTO serial 88259058
CYTOQUBE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 30, 2021
- Examiner
- AVENT, TEAGUE A
- Law office
- TMO LAW OFFICE 126
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with CYTOQUBE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Cell analyzer, namely, flow cytometers and flow-based analyzers providing cell analysis, detection, or counting for scientific, laboratory, and general research uses and imaging cytometers, being microscopes, and replacement parts and structural parts therefor; Cell imaging apparatus, namely, microscopes and imaging cytometers, multimode plate readers, and replacement parts and structural parts therefor; Flow cytometers providing cell analysis, detection, or counting for scientific, laboratory, and general research uses, and replacement parts and structural parts therefor; Microplate readers, and replacement parts and structural parts therefor; Drug screening apparatus for laboratory use, namely, research laboratory analyzers for measuring, testing, and analyzing blood and other bodily fluids, cell, bacteria and microbes and replacement parts and structural parts therefor; Cell screening apparatus for laboratory use, namely, scanning probe microscopes, and replacement parts and structural parts therefor; Photosensors being laboratory instruments, namely, radiation devices in the nature of ultraviolet, visible, or infra-red light boxes for the analysis of blood and other bodily fluids, cell, bacteria and microbes and replacement parts and structural parts therefor; Photometers, and replacement parts and structural parts therefor; Bioimaging apparatus, namely, imaging apparatus using light or fluorescence as sources for imaging human and animal tissue for scientific, laboratory and research use, and replacement parts and structural parts therefor; Electronic image acquisition apparatus, namely, optical modules for acquiring images comprised of sensors, light and stage, and replacement parts and structural parts therefor; Electronic image analysis apparatus, namely, scanners for capturing images for analysis, testing and measurement for use in life sciences research, and replacement parts and structural parts therefor; Electronic image processing apparatus, namely, scanners for capturing images for analysis, testing and measurement for use in life sciences research, and replacement parts and structural parts therefor; Downloadable computer software for acquiring, analyzing and processing electronic images; Data processing apparatus, and replacement parts and structural parts therefor; Microscopes, and replacement parts and structural parts therefor; Electronic microscopes, and replacement parts and structural parts therefor; Cameras, and replacement parts and structural parts therefor; Digital cameras, and replacement parts and structural parts therefor | ACTIVE | — |
| 010 | Cell analyzer for medical use, namely, flow cytometers and flow-based analyzers providing cell analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses, and replacement parts and structural parts therefor; Testing apparatus for medical use, namely, blood testing apparatus, and replacement parts and structural parts therefor; Diagnostic apparatus for medical use, namely, ultrasonic medical diagnostic apparatus, and replacement parts and structural parts therefor; Measuring or testing machines and instruments for medical use, namely, x-ray diagnostic apparatus, and replacement parts and structural parts therefor; Analyzing apparatus for medical use, namely, medical diagnostic apparatus for analyzing and measuring electrolytes, and replacement parts and structural parts therefor; Diagnostic imaging apparatus for medical use, namely, nuclear medicine diagnostic imaging apparatus, and replacement parts and structural parts therefor | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HAMAMATSU PHOTONICS K.K.
- Other trademarks owned by HAMAMATSU PHOTONICS K.K.
- Other trademarks owned by HAMAMATSU PHOTONICS K.K.
- Other trademarks in Class 009
- Other trademarks in Class 010
- Similar marks named CYTOQUBE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 30, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 30, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 12, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 12, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 23, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 7, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 16, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 16, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 16, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 16, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 21, 2020 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 21, 2020 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 21, 2020 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Aug 22, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 21, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 30, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 30, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 30, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 30, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 30, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 22, 2019 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Oct 28, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Oct 28, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Oct 28, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 3, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 3, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 30, 2019 | ALIE | ASSIGNED TO LIE | — |
| Sep 20, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 27, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 19, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 4, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 15, 2019 | NWAP | NEW APPLICATION ENTERED | — |